 |
인쇄하기
취소
|
Pfizer’s Lipitor patent rejected by patent court
The Patent Court of Korea has made its ruling against two patents that Pfizer holds on Lipitor, its top-selling cholesterol drug.
Despite the court’s rejection over Lipitor patents, Pfizer Korea said it will appeal the case to the Supreme Court.
Lipitor is the best-selling drug in the world, with $12.9 billion in sales in 2006. However, it has faced pressure not only from ongoing patent c...
Despite the court’s rejection over Lipitor patents, Pfizer Korea said it will appeal the case to the Supreme Court.
Lipitor is the best-selling drug in the world, with $12.9 billion in sales in 2006. However, it has faced pressure not only from ongoing patent c...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.